RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...

RBC Capital analyst Brian Abrahams maintained a Buy rating on Regeneron (REGN – Research Report) on January 21 and set a price target of ...

In a report released yesterday, Deane Dray from RBC Capital maintained a Sell rating on 3M (MMM – Research Report), with a price target of ...

Wells Fargo has recently reduced T-Mobile Us Inc (TMUS) stock to Equal Weight rating, as announced on January 6, 2025, according to Finviz. Earlier, on January 6, 2025, RBC Capital Mkts had reduced ...

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, ...

Dyne Therapeutics Inc (DYN) stock saw a decline, ending the day at $14.13 which represents a decrease of $-0.64 or -4.33% from the prior close of $14.77. The stock opened at $14.89 and touched a low ...

On Thursday, RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price target to $260 from the previous $248, while retaining an ...

In his latest memo named “On Bubble Watch,” Howard Marks, co-founder and co-chairman of Oaktree Capital ... the optimism that has prevailed in the markets since late 2022, the above average ...

On Thursday, RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price target to $260 from the previous $248, while retaining an ...

Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove ...

Daniel Fannon; Analyst; Jefferies & Company Inc. Gerard Cassidy; Analyst; RBC Capital Markets ...